Turn Therapeutics (TTRX) News
NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TTRX news summary
We found 2 recent headlines mentioning Turn Therapeutics (TTRX): 0 in the past week and 1 in the past 30 days, most often from Business Wire, Nasdaq. TTRX is making an outsized move today, down 6.31% at $8.10, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results", was published by Business Wire on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Turn Therapeutics headlines
- Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial ResultsWESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory and infectious…Business Wire
- WBB Securities Upgrades Turn Therapeutics to Hold from SellFintel reports that on October 23, 2026, WBB Securities upgraded their outlook for Turn Therapeutics (NASDAQGM:TTRX) from Sell to Hold. This rating action follows a prior action by the same firm on…NasdaqTTRX, BF.A